BridgeBio Pharma Launches Eidos Therapeutics To Develop Targeted Therapy For Fatal Heart Disease

Thursday, April 27, 2017 1 min read

Key Takeaway: BridgeBio Pharma Launches Eidos Therapeutics To Develop Targeted Therapy For Fatal Heart Disease

Full Press Release Details

BridgeBio Pharma Launches Eidos Therapeutics To Develop Targeted Therapy For Fatal Heart Disease.